0001209191-23-036529.txt : 20230612
0001209191-23-036529.hdr.sgml : 20230612
20230612204818
ACCESSION NUMBER: 0001209191-23-036529
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230608
FILED AS OF DATE: 20230612
DATE AS OF CHANGE: 20230612
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schneyer Mark C.
CENTRAL INDEX KEY: 0001899977
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50768
FILM NUMBER: 231010030
MAIL ADDRESS:
STREET 1: C/O ACADIA PHARMACEUTICALS INC.
STREET 2: 12830 EL CAMINO REAL, SUITE 400
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001070494
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 061376651
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3611 VALLEY CENTRE DRIVE
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-558-2871
MAIL ADDRESS:
STREET 1: 3611 VALLEY CENTRE DRIVE
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-08
0
0001070494
ACADIA PHARMACEUTICALS INC
ACAD
0001899977
Schneyer Mark C.
C/O ACADIA PHARMACEUTICALS INC.
12830 EL CAMINO REAL, SUITE 400
SAN DIEGO
CA
92130
0
1
0
0
EVP, Chief Financial Officer
0
Common Stock
2023-06-08
4
M
0
1893
0.00
A
23798
D
Common Stock
2023-06-08
4
S
0
974
25.02
D
22824
D
Restricted Stock Units
2023-06-08
4
M
0
1893
0.00
D
Common Stock
1893
1893
D
The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units.
Each restricted stock unit represents a contingent right to receive one share of Acadia common stock.
The restricted stock units vest in three equal annual installments on each of June 8, 2022, June 8, 2023 and June 8, 2024.
/s/ Austin D. Kim, Attorney-in-Fact
2023-06-12